September 23, 2014 2:49 PM ET

Healthcare Equipment and Supplies

Company Overview of Bausch & Lomb Incorporated

Company Overview

Bausch & Lomb Incorporated produces eye care products. The company offers contact and hydrophobic acrylic intraocular lenses; contact lens care, dry eye, allergy/redness relief, pharmaceutical, and surgical products; and eye vitamins and vision accessories. It also offers contract manufacturing services for sterile and non-sterile solutions, suspensions, ointments, gels, creams, nasals, and injectables. The company was formerly known as Bausch & Lomb Optical Company and changed its name to Bausch & Lomb Incorporated in March 1960. Bausch & Lomb Incorporated was founded in 1853 and is based in Rochester, New York. It has additional offices in Argentina, Australia, Austria, Belgium, Bulgaria, ...

1400 North Goodman Street

Rochester, NY 14609

United States

Founded in 1853

13,000 Employees

Phone:

585-338-6000

Fax:

585-338-6896

Key Executives for Bausch & Lomb Incorporated

President and Chief Financial Officer
Age: 53
President of Asia-Pacific
Age: 69
Corporate Vice President and Global President of Pharmaceuticals Business
Age: 46
Corporate Vice President and President of Latin America Operations
Global President of Vision Care Business
Age: 58
Compensation as of Fiscal Year 2014.

Bausch & Lomb Incorporated Key Developments

Bausch+Lomb Announces Opening of New Manufacturing Line to Produce New ULTRA Contact Lens

U.S. Senator Charles E. Schumer joined with Bausch+Lomb employees to celebrate the opening of a new manufacturing line that will be used to produce the new ULTRA contact lens. This new production is expected to create 120 jobs and help retain over 1,000 employees in RandD and manufacturing. Schumer said that this new contact lens line is a major victory for the Rochester economy and demonstrates Bausch+Lomb parent company Valeants commitment to growing manufacturing in Rochester. Schumer discussed his role in urging the company to produce this new contact lens line in Rochester, where it was originally developed, instead of Ireland, where the company was initially considering manufacturing the product. ULTRA is one of nine new cutting edge products that B+L is launching, and therefore will be a major focus of B+Ls push to gain a larger share of the contact lens market. Schumer said that Valeants ultimate decision to manufacture the ULTRA line in Rochester will result in new jobs for Rochester-Finger Lakes residents and enhance the entire regional economy. Specifically, this new production line is expected to create 120 jobs and help retain over 1,000 employees in RandD and manufacturing. Moreover, Schumer said, it will further cement B+Ls presence in the region for a generation. Thus far, the first of the full-scale manufacturing lines has been installed in the Rochester plant and the final testing is being completed. The second full-scale manufacturing line is slated to be installed this coming fall. Schumer said that Valeant is investing over $106 million to install two full-scale manufacturing lines to produce the new ULTRA contact lenses in Rochester. Specifically under the direction of Rochester-based general contractor LaChase Construction, B+L has put more than 240 construction and trades workers to work renovating a large portion of B+L's Rochester manufacturing facility on North Goodman Street into a new Optics Center where the two new Bausch + Lomb ULTRA manufacturing lines are being installed. In total, the contractors have dedicated approximately 65,000 straight hours of work, including 2,050 overnight hours.

Nicox to Co-Promote Latanoprostene Bunod in US with Bausch + Lomb

Nicox SA announced its decision to exercise rights to co-promote latanoprostene bunod in the US with Bausch + Lomb. According to the terms of a licensing agreement signed by the two companies in 2010, Nicox retains the possibility to co-promote latanoprostene bunod in the US.

Bausch & Lomb Inc. Wins $16.69 Million Federal Contract

Bausch & Lomb Inc. won a $16,689,720.96 federal contract from the U.S. Department of Veterans Affairs' National Acquisition Center, Chicago, for PreserVision Areds 2 Formula and PreserVision Areds Lutein.

Similar Private Companies By Industry

Company Name Region
Manoa Medical, Inc. United States
U-Systems, Inc. United States
Biological Defense Systems Inc. United States
SurgiTech United States
Firstcall Healthcare, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bausch & Lomb Incorporated, please visit www.bausch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.